Biofrontera AG (BFRA) Stock Analysis

What Biofrontera AG does

Biofrontera AG is a biopharmaceutical firm dedicated to the creation and marketing of pharmaceutical solutions. The company primarily targets dermatological ailments and conditions predominantly arising from sun exposure and its harmful effects on the skin. Central to its product offerings is Ameluz, a prescribed drug for addressing both localized lesions and broader areas affected by actinic keratosis. Biofrontera also supplies the BF-RhodoLED lamp, a device utilized in photodynamic therapy for the exact same lesion-directed and field-directed treatment of actinic keratosis. Additionally, its portfolio includes Belixos, an over-the-counter collection of skincare cosmetic products. Looking ahead, Biofrontera is progressing the development of Ameluz for treating field cancerization and nodular basal cell carcinoma. Its wider product range encompasses Xepi, a prescription antibiotic cream for impetigo, and Aktipak, a generic medication for acne. The company's products are available primarily in the United States, Europe, and Israel. Biofrontera AG also maintains a collaborative and partnership agreement with Maruho Co., Ltd. Established in 1997, the company's main office is located in Leverkusen, Germany.

Key metrics

ETFs linked to BFRA

Broad-market and Healthcare sector ETFs an investor holding Biofrontera AG is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BFRA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Biofrontera AG?

Biofrontera AG trades under the ticker BFRA on NASDAQ.

Which exchange is BFRA listed on?

BFRA is listed on NASDAQ.

What sector does Biofrontera AG operate in?

Biofrontera AG is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze BFRA in a portfolio?

PortView shows BFRA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.